Making any moves now as a director would incure a lot more...

Making any moves now as a director would incure a lot more scrutiny than the buying after release of investor presentation to the market.

Probably not director selling. It's more likely a response to the current market across all small/micro caps, tech, bio and pharma on the asx. Last few days have been bloodbath after bloodbath following the drop of the dow and nasdaq.

People are unsure, people are panic selling, stop losses are being hit, market movement is all red on average over the last 7 or so weeks.

Sure is a fun time to have everything already invested watching itnturn from overall profit to overall loss isn't it...